+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dacryocystitis Market 2020-2026

  • PDF Icon

    Report

  • July 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5145193
Global Dacryocystitis Market Size, Share & Trends Analysis Report by Indication (Acute, Chronic, and Others), and Forecast 2020-2026.

The global Dacryocystitis market is projected to grow at a significant CAGR during the forecast period. The primary factors that drive the growth of the market include the increased prevalence of dacryocystitis across the globe. Further, the advancements by the players in order to develop the advanced treatment option further drive the market growth. However, the unavailability of treatment options in underdeveloped economies is likely to hamper the growth of the market during the forecast period. Nevertheless, novel product launches along with the expansion and creating awareness in the emerging economies create scope for the market growth.

The global dacryocystitis market is segmented on the basis of indication into acute, chronic, and others including congenital. Acute dacryocystitis is projected to grow significantly over the forecast period. Geographically, the study of the global dacryocystitis market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global dacryocystitis market during the forecast period. North America is expected to hold significant share in the global dacryocystitis market owing to the increasing spending on healthcare along with the advanced treatment techniques.

Further, Pfizer Inc., Cigna, Novartis International AG, Akorn Inc., and Alembic Pharmaceuticals are some of the players covered in the global dacryocystitis market report. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market.

Research Methodology

The market study of the global dacryocystitis market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceutical companies, ophthalmic companies, research institutes, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global Dacryocystitis Market Research and Analysis by Indication

The Report Covers
  • Comprehensive research methodology of the global dacryocystitis market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global dacryocystitis market.
  • Insights about market determinants which are stimulating the global dacryocystitis market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Dacryocystitis Market by Indication
5.1.1. Acute
5.1.2. Chronic
5.1.3. Others (Congenital)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Akorn, Inc.
7.2. Alembic Pharmaceuticals Ltd.
7.3. Aurobindo Pharma Ltd.
7.4. Bess Medizintechnik GmbH
7.5. Cigna
7.6. Cipla Ltd.
7.7. Eyevance Pharmaceuticals
7.8. Gunther Weiss Scientific Glass Co. Inc.
7.9. FCI Ophthalmics
7.10. GlaxoSmithKline Plc
7.11. Kaneka Corp.
7.12. LABIANA GROUP
7.13. Merck & Co. Inc.
7.14. Mylan NV
7.15. Nosch
7.16. Novartis International AG
7.17. Orex Pharma Pvt. Ltd.
7.18. Perrigo Co.
7.19. Pfizer Inc.
7.20. PRODECO PHARMA Srl
7.21. Rexall Pharmacy Group Ltd. (McKesson Corp.)
7.22. Teligent, Inc.
LIST OF TABLES
1. GLOBAL DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2019-2026 ($ MILLION)
2. GLOBAL ACUTE DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL CHRONIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL OTHER DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
6. NORTH AMERICAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
7. NORTH AMERICAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2019-2026 ($ MILLION)
8. EUROPEAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
9. EUROPEAN DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2019-2026 ($ MILLION)
10. ASIA-PACIFIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
11. ASIA-PACIFIC DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2019-2026 ($ MILLION)
12. REST OF THE WORLD DACRYOCYSTITIS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2019-2026 ($ MILLION)
LIST OF FIGURES
1. GLOBAL DACRYOCYSTITIS MARKET SHARE BY INDICATION, 2019 VS 2026 (%)
2. GLOBAL DACRYOCYSTITIS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
3. US DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
4. CANADA DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
5. UK DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
6. FRANCE DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
7. GERMANY DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
8. ITALY DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
9. SPAIN DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
10. ROE DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
11. INDIA DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
12. CHINA DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
13. JAPAN DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
14. REST OF ASIA-PACIFIC DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION)
15. REST OF THE WORLD DACRYOCYSTITIS MARKET SIZE, 2019-2026 ($ MILLION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Akorn, Inc.
  • Alembic Pharmaceuticals Ltd.
  • Aurobindo Pharma Ltd.
  • Bess Medizintechnik GmbH
  • Cigna
  • Cipla Ltd.
  • Eyevance Pharmaceuticals
  • Gunther Weiss Scientific Glass Co. Inc.
  • FCI Ophthalmics
  • GlaxoSmithKline Plc
  • Kaneka Corp.
  • LABIANA GROUP
  • Merck & Co. Inc.
  • Mylan NV
  • Nosch
  • Novartis International AG
  • Orex Pharma Pvt. Ltd.
  • Perrigo Co.
  • Pfizer Inc.
  • PRODECO PHARMA Srl
  • Rexall Pharmacy Group Ltd. (McKesson Corp.)
  • Teligent, Inc.